Fennec Pharmaceuticals Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Research Triangle Park, NC
FENC chart
What traders are saying about $FENC
Latest postsFennec Pharmaceuticals Inc. news
- Fennec Pharmaceuticals Inc. expected to post earnings of 9 cents a share - Earnings Preview
TradingView ·
- Fennec Pharmaceuticals Inc. (RV4A.DE) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Fennec Pharmaceuticals Inc. (FENC) Seasonal returns chart
Yahoo Finance UK ·
- Fennec Pharmaceuticals sets Q3FY26 earnings release for November 12
scanx.trade ·
- Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 12, 2026
Yahoo Finance ·
- An 8:30 a.m. call will cover Fennec's quarterly results on Nov. 12.
Stock Titan ·
- C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Form 4 FENNEC PHARMACEUTICALS INC.: Terry L. Evans (Chief Commercial Officer) For: 31 October
Investing.com Canada ·
- Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026
Yahoo Finance ·
- Fennec Pharmaceuticals (FENC) Stock Sees Fair Value Lift As Analysts Raise PEDMARK Views
Yahoo Finance ·
- Can Adherex Technologies (FENC) Climb 26.53% to Reach the Level Wall Street Analysts Expect?
Yahoo Finance ·
- Fennec Pharmaceuticals Inc (FENC) (Q2 2026) Earnings Call Highlights: Record Sales and ...
Yahoo Finance ·
Fennec Pharmaceuticals Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $44.6M | $47.5M | $21.3M | $1.5M |
| Net income | -$9.74B | -$436.0M | -$16.05B | -$23.7M |
| Diluted EPS | $-0.34 | $-0.02 | $-0.60 | $-0.90 |
| Total assets (year end) | $70.6M | $44.9M | $26.9M | $26.9M |
| Cash and equivalents (year end) | $36.8M | $26.6M | $13.3M | $23.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Fennec Pharmaceuticals Inc.
- Ticker
- FENC (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Research Triangle Park, NC
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1211583
- Former names
- ADHEREX TECHNOLOGIES INC
Frequently asked questions
What exchange is Fennec Pharmaceuticals Inc. listed on?
Fennec Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol FENC.
What industry is Fennec Pharmaceuticals Inc. in?
Fennec Pharmaceuticals Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Fennec Pharmaceuticals Inc. headquartered?
Fennec Pharmaceuticals Inc.'s business address on file with the SEC is in Research Triangle Park, NC.
When does Fennec Pharmaceuticals Inc.'s fiscal year end?
Fennec Pharmaceuticals Inc.'s fiscal year ends on December 31.
How much revenue did Fennec Pharmaceuticals Inc. report?
Fennec Pharmaceuticals Inc. reported $44.6M in revenue for calendar year 2025, according to its SEC filings.